These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4462759)

  • 1. [Influence of arginine pyroglutamate on pentobarbital anesthesia].
    Provenzano PM; Brucato A; Gianguzza eS
    Boll Soc Ital Biol Sper; 1974 Nov; 50(21):1753-7. PubMed ID: 4462759
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemistry and pharmacology of arginine pyroglutamate. Analysis of its effects on the CNS.
    Provenzano PM; Brucato A; Gianguzza S; Coppola A; Orzalesi G; Selleri R; Innocenti F; Volpato I
    Arzneimittelforschung; 1977; 27(8):1553-7. PubMed ID: 578745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemico-pharmaceutical and pharmacodynamic characteristics of pyrglutargine].
    Selleri R; Orzalesi G; Innocenti F; Volpato I; Bisagno T
    Boll Chim Farm; 1977 Dec; 116(12):735-43. PubMed ID: 610732
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of pyridoxine-pyrrolidone-carboxylate on hepatic adenosine triphosphate levels in rats.
    Baldacci M; Catalani R; Bartoli C; Mura U
    Boll Soc Ital Biol Sper; 1982 Dec; 58(24):1643-9. PubMed ID: 7168788
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental study of some pharmacodynamic properties of magnesium 2-pyrrolidone-5-carboxylate].
    Binet P; Miocque M; Pechery C; Roux M; Rinjard P
    Therapie; 1976; 31(4):471-81. PubMed ID: 137552
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of pyridoxine-pyrrolidon-carboxylate on hepatic and cerebral ATP levels in ethanol treated rats.
    Felicioli R; Saracchi I; Flagiello AM; Bartoli C
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):277-80. PubMed ID: 7192694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of a drug composition containing pyroglutamic acid and pyrrolidone on the cerebral circulation].
    Lun'shina EV; Gan'shina TS; Mirzoian RS
    Eksp Klin Farmakol; 2002; 65(3):3-5. PubMed ID: 12227092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ovulation in swine following administration of centralized action preparations].
    Klinskiĭ IuD; Bashkeev ED; Krasikova ZS
    Arch Exp Veterinarmed; 1982 Jan; 36(1):99-102. PubMed ID: 7046679
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of an antiischemic drug combination and nimodipine on cerebral blood supply in a hemorrhagic stroke model in rats].
    Mirzoian NR; Gan'shina TS; Kurdiumov IN; Bero RS
    Eksp Klin Farmakol; 2008; 71(2):17-20. PubMed ID: 18488901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlations of pharmacokinetics and pharmacodynamics of a combined preparation containing pyrrolidone and pyroglutamic acid].
    Sariev AK; Lun'shina EV; Zherdev VP; Mirzoian NR
    Eksp Klin Farmakol; 2006; 69(2):58-61. PubMed ID: 16845944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of PGT/1A, a new immunostimulating drug, on macrophages and lymphocytes in immunodepressed mice.
    Barchielli M; Coppi G
    Acta Physiol Hung; 1990; 75 Suppl():25-6. PubMed ID: 2371881
    [No Abstract]   [Full Text] [Related]  

  • 12. [Synthesis and pharmacological activity of some carboxy pyrrolidinones and several derivatives (author's transl)].
    Robert J; Boucherle A
    Ann Pharm Fr; 1981; 39(4):337-46. PubMed ID: 7305244
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of penetration-enhancing ability of laurocapram, N-methyl-2-pyrrolidone and dodecyl-L-pyroglutamate.
    Príborský J; Takayama K; Nagai T; Waitzová D; Elis J; Makino Y; Suzuki Y
    Pharm Weekbl Sci; 1988 Oct; 10(5):189-92. PubMed ID: 3060835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The "forgotten" amino acid pyroglutamate.
    Moret C; Briley M
    Trends Pharmacol Sci; 1988 Aug; 9(8):278-9. PubMed ID: 3250051
    [No Abstract]   [Full Text] [Related]  

  • 15. [Medazepam and metoclopramide in experimental barbiturate narcosis].
    Sestini G; Zagaria F
    Farmaco Prat; 1976 Oct; 31(10):502. PubMed ID: 14018
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic flurazepam treatment produces decreased efficacy of the benzodiazepine ligands and pentobarbital with gamma-aminobutyric acidA receptors in cortical neurons.
    Hu XJ; Ticku MK
    J Pharmacol Exp Ther; 1994 Aug; 270(2):485-90. PubMed ID: 8071841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oleyl pyroglutamate for use as transdermal enhancer and its enhancing mechanism].
    Cheng ZY; Chen HF
    Yao Xue Xue Bao; 2003 May; 38(5):384-7. PubMed ID: 12958846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capillary electrophoresis for caffeine and pyroglutamate determination in coffees study of the in vivo effect on learning and locomotor activity in mice.
    Maeso N; del Castillo C; Cornejo L; García-Acicollar M; Alguacil LF; Barbas C
    J Pharm Biomed Anal; 2006 Jun; 41(4):1095-100. PubMed ID: 16546340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General anesthesia for ureteral measurements in the rabbit.
    Becker AJ; Stief CG; Truss MC; Meyer M; Forssmann WG; Jonas U
    J Exp Anim Sci; 1996-1997; 38(2):93-100. PubMed ID: 9226967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain penetration of orally administered sodium pyroglutamate.
    Chanal JL; Audran M; Sicard MT; Briley M
    J Pharm Pharmacol; 1988 Aug; 40(8):584-5. PubMed ID: 2907018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.